Your Words Can Make You Sick

From eNewsletter 3/2/2026

DID YOU KNOW that as more research explores lutein and zeaxanthin, the more benefits are discovered? Two recent studies suggest these two powerhouse phytochemicals are not just for eye health.

A study from The Journal of Nutrition found that lutein reduced arterial stiffness, thus protecting cardiovascular and neurovascular health.

Zeaxanthin may act as an immune-boosting compound by strengthening the cancer-fighting activity of immune cells, according to findings from Cell Reports Medicine. The results highlight the potential of zeaxanthin to improve the effectiveness of cancer immunotherapies.

To read the rest of today's issue, please go to this page.

Eat More With Less Calories | Sale Ending

From eNewsletter 2/25/2026

DID YOU KNOW that one of the reasons older adults suffer from sarcopenia, or loss of muscle mass, is pancreatic enzyme insufficiency?

As we age, we slowly lose the ability to produce sufficient enzymes in our small intestine to break down proteins, fats, and carbohydrates. This is called pancreatic enzyme insufficiency.

A recent study in Clinical Nutrition found that about 20% of older adults produce too little lipase to break down fats. After adding a pancreatic/digestive enzyme with lipase, the study subjects digested fats much better.

To read the rest of today's issue, please go to this page.

Age-Related Issues | Sale

From eNewsletter 2/23/2026

DID YOU KNOW that Clostridioides difficile infection (C. diff) of the gastrointestinal tract is a serious healthcare-associated infection that plagues hospitals and out-patient clinics?

A study from Frontiers in Nutrition examined the efficacy of certain probiotics and gut bacteria modifiers for their efficacy in preventing C. diff.

Wouldn't you know it that the most effective combination for preventing C. diff was a combination of saccharomyces boulardii and lactobacillus and bifidus probiotic strains? That happens to be the formula of Metagenics UltraFlora Acute Care!

To read the rest of today's issue, please go to this page.